Spokane Taxotere Lawyer
Taxotere can permanently alter the way you look, and many patients are not being warned of that risk. If you’ve suffered permanent hair loss after taking Taxotere, a Spokane Taxotere attorney can get you the compensation you deserve.
Following the initial pain of learning you have cancer, the treatment period can only add to the stress of the experience. Having to accommodate to treatment procedures and deal with apprehension about the future can be a heavy burden.
For some patients, a chemotherapy drug has unnecessarily compounded that burden by causing permanent hair loss. Some women with breast cancer who were treated with the drug Taxotere (generically known as docetaxel) found that their hair did not grow back once treatment stopped.
If you are one of these patients, Craig Swapp and Associates will fight to earn you fair compensation for your losses. A highly qualified Spokane Taxotere lawyer from our firm will work tirelessly with you to ensure your case ends favorably.
What Is Taxotere?
Taxotere is a chemotherapy drug the U.S. Food and Drug Administration (FDA) first approved for use in 1996. It was created by the pharmaceutical company Sanofi-Aventis and is primarily used to treat breast cancer, but it has also been approved for treatment of a number of other diseases, such as ovarian cancer, small cell lung cancer, esophageal cancer, and bladder cancer.
Although it appears competent in its chemotherapy role, Taxotere also brought with it the unfortunate side effect of permanent alopecia, otherwise known as hair loss.
How Does Taxotere Affect Patients?
The effects of permanent hair loss resulting from the use of Taxotere can be serious and long-lasting. Effects may include the following:
- Emotional anxiety
- Loss of income or earning ability
- Inability to partake in activities
- Negative impact on social relationships
- Decreased enjoyment of life
Sanofi-Aventis Might Have Held Back Info
Sanofi-Aventis appears to have been aware of Taxotere’s negative side effects before it released that information in the United States. In 2005, the company notified Europe of the negative impact the drug could make on patients. Then, in 2012, Health Canada warned Canadians of Taxotere’s noxious effects. Meanwhile, the U.S. remained unaware of these developments.
It was not until December of 2015 that the FDA ordered Sanofi-Aventis to label Taxotere products with warnings about the potential for permanent hair loss. By this time, it was too late for many patients who had already used the drug and subsequently suffered.
It is clear that Sanofi-Aventis created an unsafe product and withheld critical information from the public. If such had not been the case, patients could have avoided Taxotere. An experienced Spokane Taxotere attorney with our firm will be able to use these facts to fight for the compensation you deserve.
Contact a Defective Drug Attorney
You shouldn’t have to deal with permanent hair loss after you’ve already survived cancer. If Taxotere caused you to have permanent alopecia, you deserve compensation.